PCRX
Pacira BioSciences Inc. Healthcare - Biotechnology Investor Relations →
Pacira BioSciences Inc. (PCRX) closed at $21.00 as of 2026-02-02, trading 36.5% below its 200-week moving average of $33.07. This places PCRX in the extreme value zone. The stock moved further from the line this week, up from -38.5% last week. The 14-week RSI sits at 49, indicating neutral momentum.
Over the past 735 weeks of data, PCRX has crossed below its 200-week moving average 10 times. On average, these episodes lasted 38 weeks. Historically, investors who bought PCRX at the start of these episodes saw an average one-year return of +13.3%.
With a market cap of $903 million, PCRX is a small-cap stock. The company generates a free cash flow yield of 8.7%, which is notably high. Return on equity stands at 2.9%. The stock trades at 1.2x book value.
Share count has increased 3.4% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 14.2 years, a hypothetical investment of $100 in PCRX would have grown to $196, compared to $673 for the S&P 500. PCRX has returned 4.9% annualized vs 14.4% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 30.8% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Growth of $100: PCRX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After PCRX Crosses Below the Line?
Across 10 historical episodes, buying PCRX when it crossed below its 200-week moving average produced an average return of +14.0% after 12 months (median -7.0%), compared to +21.5% for the S&P 500 over the same periods. 40% of those episodes were profitable after one year. After 24 months, the average return was +49.5% vs +52.1% for the index.
Each line shows $100 invested at the moment PCRX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
PCRX has crossed below its 200-week MA 10 times with an average 1-year return of +13.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2012 | Jan 2012 | 2 | 12.9% | +139.3% | +162.8% |
| Sep 2015 | Nov 2015 | 6 | 22.6% | -22.6% | -55.9% |
| Feb 2016 | Apr 2016 | 6 | 15.7% | -22.4% | -62.5% |
| Apr 2016 | Apr 2019 | 157 | 50.7% | -10.3% | -61.2% |
| May 2019 | Jul 2019 | 10 | 7.9% | -5.2% | -52.0% |
| Aug 2019 | Nov 2019 | 13 | 16.7% | +37.4% | -50.6% |
| Mar 2020 | May 2020 | 9 | 24.0% | +72.5% | -47.7% |
| Aug 2022 | Sep 2022 | 1 | 2.4% | -31.3% | -59.4% |
| Sep 2022 | Sep 2022 | 1 | 0.4% | -37.3% | -60.3% |
| Oct 2022 | Ongoing | 174+ | 76.1% | Ongoing | -59.3% |
| Average | 38 | — | +13.3% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02